240 related articles for article (PubMed ID: 34896114)
1. Peripherally delivered Adeno-associated viral vectors for spinal cord injury repair.
Sydney-Smith JD; Spejo AB; Warren PM; Moon LDF
Exp Neurol; 2022 Feb; 348():113945. PubMed ID: 34896114
[TBL] [Abstract][Full Text] [Related]
2. Non-viral-mediated suppression of AMIGO3 promotes disinhibited NT3-mediated regeneration of spinal cord dorsal column axons.
Almutiri S; Berry M; Logan A; Ahmed Z
Sci Rep; 2018 Jul; 8(1):10707. PubMed ID: 30013050
[TBL] [Abstract][Full Text] [Related]
3. scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease.
Bucher T; Colle MA; Wakeling E; Dubreil L; Fyfe J; Briot-Nivard D; Maquigneau M; Raoul S; Cherel Y; Astord S; Duque S; Marais T; Voit T; Moullier P; Barkats M; Joussemet B
Hum Gene Ther; 2013 Jul; 24(7):670-82. PubMed ID: 23799774
[TBL] [Abstract][Full Text] [Related]
4. The adeno-associated virus rh10 vector is an effective gene transfer system for chronic spinal cord injury.
Hoshino Y; Nishide K; Nagoshi N; Shibata S; Moritoki N; Kojima K; Tsuji O; Matsumoto M; Kohyama J; Nakamura M; Okano H
Sci Rep; 2019 Jul; 9(1):9844. PubMed ID: 31285460
[TBL] [Abstract][Full Text] [Related]
5. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy.
Gong Y; Berenson A; Laheji F; Gao G; Wang D; Ng C; Volak A; Kok R; Kreouzis V; Dijkstra IM; Kemp S; Maguire CA; Eichler F
Hum Gene Ther; 2019 May; 30(5):544-555. PubMed ID: 30358470
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals.
Hinderer C; Bell P; Katz N; Vite CH; Louboutin JP; Bote E; Yu H; Zhu Y; Casal ML; Bagel J; O'Donnell P; Wang P; Haskins ME; Goode T; Wilson JM
Hum Gene Ther; 2018 Jan; 29(1):15-24. PubMed ID: 28806897
[TBL] [Abstract][Full Text] [Related]
8. Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries.
Thomas AM; Palma JL; Shea LD
J Control Release; 2015 Apr; 204():1-10. PubMed ID: 25724274
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo non-viral vector-mediated neurotrophin-3 gene transfer to olfactory ensheathing glia: effects on axonal regeneration and functional recovery after implantation in rats with spinal cord injury.
Wu J; Sun TS; Ren JX; Wang XZ
Neurosci Bull; 2008 Apr; 24(2):57-65. PubMed ID: 18369383
[TBL] [Abstract][Full Text] [Related]
10. Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury.
Griffin JM; Fackelmeier B; Fong DM; Mouravlev A; Young D; O'Carroll SJ
Gene Ther; 2019 May; 26(5):198-210. PubMed ID: 30962538
[TBL] [Abstract][Full Text] [Related]
11. Transduction efficiency of neurons and glial cells by AAV-1, -5, -9, -rh10 and -hu11 serotypes in rat spinal cord following contusion injury.
Petrosyan HA; Alessi V; Singh V; Hunanyan AS; Levine JM; Arvanian VL
Gene Ther; 2014 Dec; 21(12):991-1000. PubMed ID: 25119378
[TBL] [Abstract][Full Text] [Related]
12. Comparison of AAV2 and AAV5 in gene transfer in the injured spinal cord of mice.
Peng SP; Kügler S; Ma ZK; Shen YQ; Schachner M
Neuroreport; 2011 Aug; 22(12):565-9. PubMed ID: 21879483
[TBL] [Abstract][Full Text] [Related]
13. Spinal cord injury and the neuron-intrinsic regeneration-associated gene program.
Fagoe ND; van Heest J; Verhaagen J
Neuromolecular Med; 2014 Dec; 16(4):799-813. PubMed ID: 25269879
[TBL] [Abstract][Full Text] [Related]
14. AAV-Mediated Gene Delivery to the Spinal Cord by Intrathecal Injection.
Peterson CD; Skorput AGJ; Kitto KF; Wilcox GL; Vulchanova L; Fairbanks CA
Methods Mol Biol; 2019; 1950():199-207. PubMed ID: 30783975
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of direct and cell-mediated triple-gene therapy in spinal cord injury in rats.
Islamov RR; Izmailov AA; Sokolov ME; Fadeev PO; Bashirov FV; Eremeev AA; Shaymardanova GF; Shmarov MM; Naroditskiy BS; Chelyshev YA; Lavrov IA; Palotás A
Brain Res Bull; 2017 Jun; 132():44-52. PubMed ID: 28529158
[TBL] [Abstract][Full Text] [Related]
16. Post-spinal cord injury astrocyte-mediated functional recovery in rats after intraspinal injection of the recombinant adenoviral vectors Ad5-VEGF and Ad5-ANG.
Povysheva T; Shmarov M; Logunov D; Naroditsky B; Shulman I; Ogurcov S; Kolesnikov P; Islamov R; Chelyshev Y
J Neurosurg Spine; 2017 Jul; 27(1):105-115. PubMed ID: 28452633
[TBL] [Abstract][Full Text] [Related]
17. Systemic AAV vectors for widespread and targeted gene delivery in rodents.
Challis RC; Ravindra Kumar S; Chan KY; Challis C; Beadle K; Jang MJ; Kim HM; Rajendran PS; Tompkins JD; Shivkumar K; Deverman BE; Gradinaru V
Nat Protoc; 2019 Feb; 14(2):379-414. PubMed ID: 30626963
[TBL] [Abstract][Full Text] [Related]
18. The use of an adeno-associated viral vector for efficient bicistronic expression of two genes in the central nervous system.
Hutson TH; Kathe C; Menezes SC; Rooney MC; Bueler H; Moon LD
Methods Mol Biol; 2014; 1162():189-207. PubMed ID: 24838969
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice.
Benkhelifa-Ziyyat S; Besse A; Roda M; Duque S; Astord S; Carcenac R; Marais T; Barkats M
Mol Ther; 2013 Feb; 21(2):282-90. PubMed ID: 23295949
[TBL] [Abstract][Full Text] [Related]
20. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems.
Chan KY; Jang MJ; Yoo BB; Greenbaum A; Ravi N; Wu WL; Sánchez-Guardado L; Lois C; Mazmanian SK; Deverman BE; Gradinaru V
Nat Neurosci; 2017 Aug; 20(8):1172-1179. PubMed ID: 28671695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
